Maspin is an angiogenesis inhibitor

Nature Medicine

Volumn 6, Issue 2, 2000, Pages 196-199

  Zhang, Ming ^a   Volpert, Olga ^b   Shi, Yihui H ^a   Bouck, Noël ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; MASPIN; SERINE PROTEINASE INHIBITOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER INHIBITION; CAPILLARY DENSITY; CELL MIGRATION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVE SITE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; RAT; TREATMENT OUTCOME; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BREAST NEOPLASMS; CATTLE; CELL MOVEMENT; CORNEA; ENDOTHELIUM, VASCULAR; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE; PROSTATIC NEOPLASMS; PROTEINS; RATS; SERPINS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033974302     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/72303     Document Type: Article

References (20)

1. Zou, Z. et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells [see comments]. Science 263, 526-529 (1994).
2. Zhang, M., Maass, N., Magit, D. & Sager, R. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ. 8, 179-186 (1997).
3. Pemberton, P.A. et al. The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin. J. Biol. Chem 270, 15832-15837(1995).
4. Sheng, S. et al. Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. Prof. Natl. Acad. SCI. U. S. A. 95, 499-504 (1998).
5. Zhang, M. et al. Maspin plays an important role in mammary gland development. Dev. Biol. 215, 278-287 (1999).
6. Stringer, H.A. & Pannekoek, H. The significance of fibrin binding by plasminogen activator inhibitor 1 for the mechanism of tissue-type plasminogen activator-mediated fibrinolysis. J. Biol. Chem. 270, 11205-11208 (1995).
7. Zhang, M., Sheng, S., Maass, N. & Sager, R. mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility. Mol. Med. 3, 49-59 (1997).
8. Sheng, S., Pemberton, P.A. & Sager, R. Production, purification, and characterization of recombinant maspin proteins. J. Biol. Chem. 269, 30988-30993 (1994).
9. Dawson, D.W. et al. CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 138, 707-717 (1997).
10. Lawrence, D.A., Berkenpas, M.B., Palaniappan, S. & Ginsburg, D. Localization of vitronectin binding domain in plasminogen activator inhibitor-1. J. Biol. Chem. 269, 15223-15228 (1994).
11. Gately, S. et al. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res. 56, 4887-4890 (1996).
12. Volpert, O.V. et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats [see comments]. J. Clin. Invest. 98, 671-679 (1996).
13. Sheng, S. et al. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl. Acad. Sci. U. S. A 93, 11669-11674 (1996).
14. Sternlicht, M.D., Kedeshian, P., Shao, Z.M., Safarians, S. & Barsky, S.H. The human myoepithelial cell is a natural tumor suppressor. Clin. Cancer Res. 3, 1949-1958 (1997).
15. Dawson, D.W. et al. Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis. Science 285, 245-248 (1999).
16. Polverini, P.J., Bouck, N.P. & Rastinejad, F. Assay and purification of naturally occurring inhibitor of angiogenesis. Methods Enzymol. 198, 440-450 (1991).
17. Tsujii, M. et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells [published erratum appears in Cell 1998 Jul 24;94(2):following 271]. Cell 93, 705-716 (1998).
18. Silberstein, G.B. & Daniel, C.W. Investigation of mouse mammary ductal growth regulation using slow-release plastic implants. J. Dairy Sci. 70, 1981-1990 (1987).
19. Talhouk, R.S., Bissell, M.J. & Werb, Z. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J. Cell Biol 118, 1271-1282 (1992).
20. Obermair, A. et al. Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 89, 1212-1217 (1997).